Viatris to Report Financial Results for the Third Quarter 2022 and Provide an Update on its February 28 Investor Event on November 7, 2022

Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) will announce its financial results for Q3 2022 on November 7, 2022, at 8:30 a.m. ET. Key executives, including Executive Chairman Robert J. Coury and CEO Michael Goettler, will host a webcast reviewing the quarterly results and an update regarding the February 28 Investor Event. Investors can access the live call via investor.viatris.com or by calling provided numbers. Viatris, established in November 2020, focuses on providing global healthcare solutions through its extensive portfolio of approved products.

Positive

• Upcoming Q3 2022 earnings report may provide insights into company performance.
• Continued engagement with investors through a webcast to discuss quarterly results.

Negative

• None.

PITTSBURGH, Oct. 24, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will announce financial results for the third quarter of 2022 on Monday, November 7, 2022. Executive Chairman Robert J. Coury, Chief Executive Officer Michael Goettler, President Rajiv Malik, and Chief Financial Officer Sanjeev Narula will host a webcast at 8:30 a.m. ET on the same date to review the quarterly results and provide an update on the company's February 28 Investor Event.

Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 800.225.9448 or 203.518.9708 for international callers (Conference ID: VTRSQ322).  A replay of the webcast also will be available on the website.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a portfolio of biosimilars and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-financial-results-for-the-third-quarter-2022-and-provide-an-update-on-its-february-28-investor-event-on-november-7-2022-301657659.html

SOURCE Viatris Inc.

FAQ

When will Viatris report its Q3 2022 financial results?

Viatris will report its Q3 2022 financial results on November 7, 2022.

Who will be hosting the Viatris earnings call for Q3 2022?

The earnings call will be hosted by Executive Chairman Robert J. Coury and CEO Michael Goettler, among others.

How can I listen to the Viatris Q3 2022 earnings call?

You can listen to the call via investor.viatris.com or by calling 800.225.9448.

What is the significance of Viatris' upcoming investor event on February 28?

The event on February 28 will provide insights into the company's strategic direction and future outlook.